[Home ] [Archive]    
:: Volume 14, Issue 1 (April& May 2009) ::
pajoohande 2009, 14(1): 47-52 Back to browse issues page
Testes Doses and Sex Hormone Changes using Different Radiotherapy Machines to Treat Rectal Cancer
Ameri A *, Alidoosti A, Mojirsheibani Kh, Sobhani M, Sharafi AA, Vallaei N
, a_ameri@sbmu.ac.ir
Abstract:   (10776 Views)
Background and Aim: Complications of pelvic irradiation have gained more attention because of increased survival of patients. CO-60 Teletherapy has wide penumbra in comparison with linear accelerator that can cause testes irradiation during radiotherapy in vicinity of lower border of pelvic portal when treated for rectal cancer. In this study we compared testicular doses of testes when pelvis is irradiated for rectal cancer and its effect on sex hormone levels. Materials and Methods: In a cohort study, rectal cancer patients treated by pelvic irradiation concomitant with chemotherapy in two group. A group treated by Co-60 Teletherapy and another group by Linear Accelerator (LINAC). Sex hormones serumic levels were measured immediately before and 3 to 6 weeks after finishing irradiation. Testicular doses were measured by TLD (LiF), 3 times during whole course of irradiation in 5 patients of each group. T test and Mann-Whitney were used to compare data. Results: 28 patients entered in study but 2 patients died early in course of radiotherapy (1 in each group), and one patient excluded because testes was inside of treatment portals. Patients and disease characteristics were similar between groups. Testes doses in patients treated by LINAC (55±24.7 mGy) was significantly lower than Co-60 (120±23 mGy) (p<0.001). FSH and LH serumic level increased after irradiation in both groups and there is not a relation between FSH and LH levels with treatment machine (p<0.2 for LINAC and p<0.6 for Co-60. Decrease in serumic levels of testosterone was significant in patients treated by CO-60 (p<0.05), but was not significant in LINAC group (p<0.3). Conclusion: It seems using LINAC in treating patient with rectal cancer can decrease testes doses but can not prevent hormonal changes. We suggest extra shield to decrease testes doses below the toxic dose.
Keywords: Sex Hormone, Testes Doses, Rectal Cancer, Radiotherapy Machine
Full-Text [PDF 205 kb]   (1663 Downloads)    
Type of Study: Original | Subject: Medicine
Received: 2017 | Accepted: 2017 | Published: 2017
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ameri A, Alidoosti A, Mojirsheibani Kh, Sobhani M, Sharafi AA, Vallaei N. Testes Doses and Sex Hormone Changes using Different Radiotherapy Machines to Treat Rectal Cancer. pajoohande. 2009; 14 (1) :47-52
URL: http://pajoohande.sbmu.ac.ir/article-1-749-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 14, Issue 1 (April& May 2009) Back to browse issues page
Persian site map - English site map - Created in 0.06 seconds with 30 queries by YEKTAWEB 4457